Indoco Remedies Ltd
NSE:INDOCO

Watchlist Manager
Indoco Remedies Ltd Logo
Indoco Remedies Ltd
NSE:INDOCO
Watchlist
Price: 330.85 INR 0.33% Market Closed
Market Cap: 30.5B INR
Have any thoughts about
Indoco Remedies Ltd?
Write Note

Indoco Remedies Ltd
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Indoco Remedies Ltd
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Indoco Remedies Ltd
NSE:INDOCO
Deferred Income Tax
â‚ą118.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Deferred Income Tax
â‚ą13.8B
CAGR 3-Years
919%
CAGR 5-Years
316%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Deferred Income Tax
â‚ą1.9B
CAGR 3-Years
-15%
CAGR 5-Years
-11%
CAGR 10-Years
-5%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Deferred Income Tax
â‚ą1.9B
CAGR 3-Years
59%
CAGR 5-Years
28%
CAGR 10-Years
-2%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Deferred Income Tax
â‚ą7.9B
CAGR 3-Years
112%
CAGR 5-Years
N/A
CAGR 10-Years
20%
M
Mankind Pharma Ltd
NSE:MANKIND
Deferred Income Tax
â‚ą890.7m
CAGR 3-Years
90%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Indoco Remedies Ltd
Glance View

Market Cap
30.5B INR
Industry
Pharmaceuticals

Indoco Remedies Ltd. engages in manufacturing and marketing of Formulations (Finished Dosage Forms) and active pharmaceutical ingredients. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2005-01-07. The firm is an integrated, research-oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The firm's geographical segments include India and Outside India. The firm has nine domestic marketing divisions with a brand portfolio in various therapeutic segments, including Gastrointestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management and Gyneacology. The Company’s brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Cal-Aid, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM and Methycal.

INDOCO Intrinsic Value
409.51 INR
Undervaluation 19%
Intrinsic Value
Price

See Also

What is Indoco Remedies Ltd's Deferred Income Tax?
Deferred Income Tax
118.3m INR

Based on the financial report for Mar 31, 2024, Indoco Remedies Ltd's Deferred Income Tax amounts to 118.3m INR.

What is Indoco Remedies Ltd's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 1Y
93%

Over the last year, the Deferred Income Tax growth was 93%.

Back to Top